Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul;17(7):383.
doi: 10.1038/s41569-020-0401-0.

RAAS inhibitors do not increase the risk of COVID-19

Irene Fernández-Ruiz  1
Affiliations
Comment

RAAS inhibitors do not increase the risk of COVID-19

Irene Fernández-Ruiz. Nat Rev Cardiol. 2020 Jul.

Abstract

According to five new studies, therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is not associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with an increased risk of severe disease or in-hospital death among patients with COVID-19.

PubMed Disclaimer

Comment on

References

    1. Mancia G, et al. Renin–angiotensin–aldosterone system blockers and the risk of Covid-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2006923. - DOI - PMC - PubMed
    1. Mehra MR, et al. Cardiovascular disease, drug therapy, and mortality in Covid-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2007621. - DOI - PMC - PubMed
    1. Reynolds HR, et al. Renin–angiotensin–aldosterone system inhibitors and risk of Covid-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2008975. - DOI - PMC - PubMed
    1. Mehta N, et al. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.1855. - DOI - PMC - PubMed
    1. de Abajo FJ, et al. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020 doi: 10.1016/S0140-6736(20)31030-8. - DOI - PMC - PubMed